These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36655820)

  • 41. Smartphone-Based Neuropsychological Assessment in Parkinson's Disease: Feasibility, Validity, and Contextually Driven Variability in Cognition.
    Weizenbaum EL; Fulford D; Torous J; Pinsky E; Kolachalama VB; Cronin-Golomb A
    J Int Neuropsychol Soc; 2022 Apr; 28(4):401-413. PubMed ID: 33998438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design and validation of a brief scale for cognitive evaluation in people with a diagnosis of schizophrenia (BCog-S).
    Sánchez-Martínez V; Sales-Orts R
    J Psychiatr Ment Health Nurs; 2020 Oct; 27(5):543-552. PubMed ID: 31976597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reliability, Validity, and User-Experience of Remote Unsupervised Computerized Neuropsychological Assessments in Community-Living 55- to 75-Year-Olds.
    Kochan NA; Heffernan M; Valenzuela M; Sachdev PS; Lam BCP; Fiatarone Singh M; Anstey KJ; Chau T; Brodaty H
    J Alzheimers Dis; 2022; 90(4):1629-1645. PubMed ID: 36314208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer-Related Cognitive Dysfunction: A Narrative Review for Clinical Practice.
    Rick O; Gerhardt A; Schilling G
    Oncol Res Treat; 2024; 47(5):218-223. PubMed ID: 38471462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brief executive-function assessment tool: A new cognitive impairment screening tool for alcohol and other drug services.
    Berry J; Shores EA; Nardo T; Sedwell A; Lunn J; Marceau EM; Wesseling A; Zucco M; Sugden-Lingard S; Borchard T; Batchelor J
    Appl Neuropsychol Adult; 2022; 29(6):1511-1521. PubMed ID: 33831338
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
    Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A 10-minute measure of global cognition: Validation of the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS).
    Hurford IM; Ventura J; Marder SR; Reise SP; Bilder RM
    Schizophr Res; 2018 May; 195():327-333. PubMed ID: 28918221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of a cognitive assessment battery administered over the telephone.
    Rapp SR; Legault C; Espeland MA; Resnick SM; Hogan PE; Coker LH; Dailey M; Shumaker SA;
    J Am Geriatr Soc; 2012 Sep; 60(9):1616-23. PubMed ID: 22985137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care.
    Rao SM; Galioto R; Sokolowski M; Pierce M; Penn L; Sturtevant A; Skugor B; Anstead B; Leverenz JB; Schindler D; Blum D; Alberts JL; Posk L
    J Alzheimers Dis; 2023; 92(3):1051-1066. PubMed ID: 36847000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of the French version of the BACS (the brief assessment of cognition in schizophrenia) among 50 French schizophrenic patients.
    Bralet MC; Falissard B; Neveu X; Lucas-Ross M; Eskenazi AM; Keefe RS
    Eur Psychiatry; 2007 Sep; 22(6):365-70. PubMed ID: 17434715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of the NIH Toolbox Cognitive Battery in intellectual disability.
    Shields RH; Kaat AJ; McKenzie FJ; Drayton A; Sansone SM; Coleman J; Michalak C; Riley K; Berry-Kravis E; Gershon RC; Widaman KF; Hessl D
    Neurology; 2020 Mar; 94(12):e1229-e1240. PubMed ID: 32094241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of the Spanish version of the Oxford Cognitive Screen (S-OCS): psychometric properties of a short cognitive stroke-specific screening tool.
    Valera-Gran D; López-Roig S; Hurtado-Pomares M; Peral-Gómez P; García-Manzanares M; Sunyer Catlla M; Más Sesé G; Navarrete-Muñoz EM; Sánchez-Pérez A
    Clin Rehabil; 2019 Apr; 33(4):724-736. PubMed ID: 30563369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coping with cancer-related cognitive dysfunction: a scoping review of the literature.
    Sleight A
    Disabil Rehabil; 2016; 38(4):400-8. PubMed ID: 25885669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in the Russian Population.
    Evdoshenko E; Laskova K; Shumilina M; Nekrashevich E; Andreeva M; Neofidov N; Kalinin I; Nikitchenko D; Rogozina A; Kupaeva A; Bulanov I; Bakirtzis C; Grigoriadis N; Khachanova N; Davydovskaya M; Makshakov G
    J Int Neuropsychol Soc; 2022 May; 28(5):503-510. PubMed ID: 34132190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validity and reliability of the Cognitive Complaints in Bipolar Disorder Rating Assessment (COBRA) in Brazilian bipolar patients.
    Lima FM; Cardoso TA; Serafim SD; Martins DS; Solé B; Martínez-Arán A; Vieta E; Rosa AR
    Trends Psychiatry Psychother; 2018; 40(2):170-178. PubMed ID: 29995161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of the Japanese Version of the Functional Assessment of Cancer Therapy-Cognitive Function Version 3.
    Miyashita M; Tsukamoto N; Hashimoto M; Kajiwara K; Kako J; Okamura H
    J Pain Symptom Manage; 2020 Jan; 59(1):139-146.e3. PubMed ID: 31654740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transdisciplinary Preliminary Evaluation of Goal Maintenance in Cancer-Related Cognitive Impairment.
    Boone AE; Hart E; Wolf TJ
    OTJR (Thorofare N J); 2022 Oct; 42(4):324-332. PubMed ID: 35761479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a three-factor neuropsychological approach for detecting minimal hepatic encephalopathy.
    Stewart CA; Enders FT; Schneider N; Felmlee-Devine D; Kamath PS; Smith GE
    Liver Int; 2010 Jul; 30(6):841-9. PubMed ID: 20412441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation and Normative Data for the Modified Telephone Interview for Cognitive Status: The Sydney Memory and Ageing Study.
    Bentvelzen AC; Crawford JD; Theobald A; Maston K; Slavin MJ; Reppermund S; Kang K; Numbers K; Brodaty H; Sachdev P; Kochan NA
    J Am Geriatr Soc; 2019 Oct; 67(10):2108-2115. PubMed ID: 31290146
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.
    Edgar C; Jongen PJ; Sanders E; Sindic C; Goffette S; Dupuis M; Jacquerye P; Guillaume D; Reznik R; Wesnes K
    BMC Neurol; 2011 Jun; 11():68. PubMed ID: 21649910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.